Niklas L. Engel

Niklas L. Engel

Auto-generated profile, based on publicly available information

Niklas L. Engel

Division of Applied Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 December 2025 in bioRxiv
Verified
Preprint
Open access
NENiklas L Engel
Niklas L Engel
BBBenedikt Brors
Benedikt Brors
LFLars Feuerbach
Lars Feuerbach
PPPeter Park
Peter Park
Telomeres are repetitive nucleoprotein structures that cap the ends of linear chromosomes and are essential for maintaining genomic stability. While individual chromosome ends maintain distinct telomere lengths, the extent of this conservation across tissues and populations remains unclear due to the difficulty of analyzing repetitive telomeric sequences. Here, we show that high-coverage whole-genome Nanopore sequencing enables robust measurement of telomere length at the level of individual chromosomes. Nanopore reads yield reproducible telomere length estimates across replicates, in contrast to PacBio HiFi reads. Across > 250 individuals from 1000 Genomes and the SMaHT projects, chromosome- specific telomere length patterns are conserved across individuals and tissues, with tissues from the same individual showing highly similar patterns. This conserved landscape suggests coordinated regulation, whose disruption may contribute to genomic instability. Nanopore sequencing also allows simultaneous detection of structural variants, including disruption of TERT and NHP2 that drive global telomere shortening. Furthermore, our quantification of telomere variant repeats in positional context indicates active telomerase-mediated elongation. Our integrated profiling of telomere length and structural variation enables inference of variant effects on chromosome-specific telomere dynamics and may uncover risk factors for short telomere syndromes and cancer. Importantly, positionally fully resolved telomeric variant repeat patterns may predict activated telomere maintenance mechanisms with high accuracy.

29 August 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
NENiklas L. Engel
Niklas L. Engel
HFHanna Frieß
Hanna Frieß
JGJulia Grigorjew
Julia Grigorjew
FPFerdinand Popp
Ferdinand Popp
LHLea Herzel
Lea Herzel
LFLars Feuerbach
Lars Feuerbach
Introduction Biological processes such as aging, carcinogenesis, and immune response rely on the ability to maintain or rapidly expand cell populations. The fitness of the involved cells is constrained by their replicative potential, which is reflected in the cellular telomere content. Method We apply TelomereHunter to scATAC-seq data to determine telomere content on single-cell level, in a hematopoietic dataset consisting of 35,139 cells from samples of basal cell carcinoma patients receiving programmed cell death protein 1 (PD1) blockade treatment. Integrating information from open-chromatin-based signatures to assess cell identity, we characterize the heterogeneity of telomere length for individual cell populations pre- and post-immunotherapy. Results The extracted telomeric reads reflect the expected telomereome-to-genome fraction. Telomere content distributions differ significantly between cell populations, and the median telomere content in intermediate and terminal exhausted CD8+ T-cells pre-treatment is significantly correlated to response to PD-1 checkpoint blockade. Likewise, telomere content correlates with post-treatment cell proliferation in terminally exhausted and T follicular helper cells from responding patients. Conclusion Telomere content measurement from scATAC-seq data has a sufficiently high signal-to-noise ratio to detect significant differences between cell types. Furthermore, the telomere content of CD8+ exhausted T-cells pre-treatment is a putative biomarker for successful PD-1-based immunotherapy.

6 September 2025 in bioRxiv
Verified
Preprint
Open access
ADAlessandro Dulja
Alessandro Dulja
MMMarvin Mayer
Marvin Mayer
NENiklas Engel
Niklas Engel
AGArkadiy Golov
Arkadiy Golov
MFMattia Forneris
Mattia Forneris
EFEileen E.M. Furlong
Eileen E.M. Furlong
Transcription involves a cycle of initiation, pausing, elongation, and termination. SPT5 regulates both promoter proximal pausing and elongation, but how it orchestrates both steps during dynamic changes in gene expression remains unclear. Here, using Drosophila embryogenesis, we show that pausing both precedes and follows gene expression, while active transcription is accompanied by pause release. Optogenetic rapid depletion of SPT5 from the nucleus uncovered different sensitivities at different developmental stages. In early embryogenesis, SPT5 depletion caused a downstream shift in Pol II pausing to the +1 nucleosome, resulting in defective elongation and early termination. In late embryogenesis, it led to both up- and downregulation of expression, depending on the genes’ transcriptional and pausing state – upregulation is caused by pause release while downregulation is due to defective elongation. These changes are intensified when genes are increasing or decreasing their transcriptional state, indicating that SPT5 contributes to fine-tuning dynamic changes in gene expression.